Retinal vein occlusion which is a major cause of blindness for millions of adults worldwide can be prevented with a new eye drops solution developed by a team of researchers.<br /><br />A study on mice suggests that the experimental therapy, which targets a common cause of neurode generation and vascular leakage in the eye, could have broader therapeutic effects than existing drugs.
